Literature DB >> 4344218

Demonstration of cytotoxic antibodies in rabbits bearing tumors induced by Shope fibroma virus.

S B Singh, J W Smith, W E Rawls, S S Tevethia.   

Abstract

The (51)Cr-release test was used to detect cytotoxic antibodies in adult rabbits bearing tumors induced by Shope fibroma virus. The following are the recommended experimental conditions: the infection of RK-13 cells with a multiplicity of 1 to 2 infectious units per cell for 48 hr, (51)Cr labeling of infected cells during the last 12 hr of incubation, sensitization of suspended labeled infected cells for 1 hr with immune serum, and quantitation of cell damage by the amount of (51)Cr released after 6 hr of incubation in the presence of complement. The immune sera reacted only with fibroma virus-infected cells but not with cells infected with vaccinia virus or herpesvirus type 1. Similarly, sera prepared against vaccinia virus and herpesvirus type 1 were not cytotoxic to fibroma virus-infected cells, although they were cytotoxic to cells infected with homologous viruses. The total antibody activity in sera of rabbits infected with Shope fibroma virus was detected first on day 7, gradually rose to its peak by day 23, and persisted at that level for at least 50 days. The 19S antibody was detected on day 7, reached peak titers by day 13, and disappeared by day 17. The 7S antibody was barely detectable on day 7, reached maximum titers on day 13, and remained high for at least 50 days. The tumors appeared on the 3rd day after virus inoculation, reached maximum size on day 13, and regressed completely by day 23.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4344218      PMCID: PMC422374          DOI: 10.1128/iai.5.3.352-358.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  A general method for the quantitation of immune cyotysis.

Authors:  H S GOODMAN
Journal:  Nature       Date:  1961-04-15       Impact factor: 49.962

2.  Characterization of surface antigen on cells infected by fibroma virus.

Authors:  W A Tompkins; N A Crouch; S S Tevethia; W E Rawls
Journal:  J Immunol       Date:  1970-11       Impact factor: 5.422

Review 3.  Antigens induced by the mouse leukemia viruses.

Authors:  G Pasternak
Journal:  Adv Cancer Res       Date:  1969       Impact factor: 6.242

Review 4.  Antigens of virus-induced tumors.

Authors:  K Habel
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

5.  Immune hemadsorption by cells infected with poxviruses.

Authors:  H Miyamoto; S Kato
Journal:  Biken J       Date:  1968-12

Review 6.  Immunological enhancement as studied by cell culture techniques.

Authors:  K E Hellström; I Hellström
Journal:  Annu Rev Microbiol       Date:  1970       Impact factor: 15.500

7.  An in vitro measure of cellular immunity to fibroma virus.

Authors:  W A Tompkins; C Adams; W E Rawls
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

8.  Immune response to Gross virus-induced lymphoma. I. Kinetics of cytotoxic antibody response.

Authors:  R B Herberman; M E Oren
Journal:  J Natl Cancer Inst       Date:  1971-02       Impact factor: 13.506

Review 9.  Tumor antigens.

Authors:  G Klein
Journal:  Annu Rev Microbiol       Date:  1966       Impact factor: 15.500

10.  The association of herpesvirus type 2 and carcinoma of the uterine cervix.

Authors:  W E Rawls; W A Tompkins; J L Melnick
Journal:  Am J Epidemiol       Date:  1969-05       Impact factor: 4.897

View more
  3 in total

1.  Depressed cell-mediated immunity in newborn rabbits bearing fibroma virus-induced tumors.

Authors:  W A Tompkins; R M Schultz; G V Rao
Journal:  Infect Immun       Date:  1973-04       Impact factor: 3.441

2.  Cytotoxic antibody response to tumors induced in adult and newborn rabbits by fibroma virus.

Authors:  W A Tompkins; R M Schultz
Journal:  Infect Immun       Date:  1972-10       Impact factor: 3.441

Review 3.  Antibody-mediated destruction of virus-infected cells.

Authors:  J G Sissons; M B Oldstone
Journal:  Adv Immunol       Date:  1980       Impact factor: 3.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.